The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in … Read more
A study led by the Institute of Bioengineering of Catalonia demonstrates that laminin, a protein present in breast tissues, prevents the effects of stiffening, protecting cells against tumor growth. While the mechanism has been demonstrated in vitro, persuasive indications suggest its potential applicability in vivo, as observed in patient samples.
Samuel Sánchez has successfully secured an “ERC Proof of Concept” grant, provided by the European Research Council (ERC), to explore the application of his nanorobots in the treatment of mucus-secreting tumors. This prestigious grant enables researchers to assess the feasibility and potential for knowledge transfer of their research projects.
IBEC researchers uncover how mechanical forces disrupt the circadian clock in cells, the mechanism governing daily physiological changes. The finding may help to better understand aging and specific diseases, like … Read more
Today marked the second edition of the BASF-ICIQ Innovation and Entrepreneurship Awards, which reward excellence in the field of chemistry. The biomedical company Nanobots Therapeutics S.L., led by Prof. Samuel … Read more
Researchers from the IBEC and the University of Barcelona (UB) have identified new biomarkers for non-small cell lung cancer, the most common lung cancer. The results, published in the journal Modern … Read more
A recent IBEC study has described how cells contact guidance is not only topography-dependent but also affected by the stiffness of the environment. The work highlights the importance of considering … Read more
Nanobots Therapeutics is the spin-off recently created by the Institute of Bioengineering of Catalonia (IBEC) and the Catalan Institution for Research and Advanced Studies (ICREA) that proposes to develop a … Read more
A study led by Jordi Alcaraz, associated researcher at IBEC and professor at the University of Barcelona, in collaboration with the Hospital Clínic, has determined that the TIMP-1 protein is … Read more
IBEC researchers led by Elisabeth Engel are in the media for their new tool against breast cancer: 3D bioprinting of tumors using pig tissue. The study, led by group leader … Read more